medigraphic.com
ISSN 2078-7162 (Print)

2013, Number 1

<< Back Next >>

Rev Cub de Med Fis y Rehab 2013; 5 (1)

Prevention of the stroke with the application of ozone therapy

Borroto RV, Lima HLB, Lima GS, Marín DME, Castellanos SJC, Cambara PR

Language: Spanish
References: 31
Page: 3-16
PDF size: 139.46 Kb.


ABSTRACT

Objective: to determine the effect of the ozone therapy in the control of the factors of risk of the stroke.
Method: was carried out in Service of Quality of Life of the National Center of Natural and Traditional Medicine a study from January 2007 to December 2009 where it was carried out an analysis of 120 patients with different factors of risk of presenting stroke. (age, diabetes mellitus, hypertension, level of fats increased in blood, heart disease) with the objective of determining the effect of the ozone therapy in the prevention of the stroke, it was divided the sample aleatorily in 60 patients each one to the one that was applied treatment with rectal ozone in an upward dose for 20 daily sessions every three months until completing four cycles, more the established conventional therapy for these pathologies and another group to the one that alone it was applied the conventional therapy, to all they were carried out an evaluation before the treatment and every three months after each cycle, the biochemical and clinical parameters.
Results: the results were that the patients that received treatment with ozone therapy stayed more stable from the clinical and biochemical point of view than the group control and they didn't present any complication vascular brain.
Conclusions: the ozone therapy applied with the used protocol was useful as helping in the control of the heart disease, risk of vascular illnesses of brain, in the other factors of studied waterings, a tendency that indicates exists that it can be significant but it is required of a bigger sample to determine it. Adverse events were not presented.


REFERENCES

  1. Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76(6 Suppl):S8590. Revista Cubana de Medicina Física y Rehabilitación 2013;5(1):3-16 14

  2. González Romo R, Armas Rodríguez L, Gavilla González B, Justa Díaz Camellón D. Enfermedad cerebrovascular en el Policlínico Docente José Antonio Echevarría, de Cárdenas. Rev Méd Electrón [Internet]. 2013 Ene-Feb [citado: fecha de acceso];35(1). Disponible en: http://www.revmatanzas.sld.cu/revista%20medica/ano%202013/vol1%202013/te ma02.htm

  3. Ministerio de salud pública. Anuario estadístico 2010. [Citado 8 de Mayo del 2012]. Disponible en: http://www.sld.cu/sitios/dne

  4. Ministerio de Salud Pública. Anuario Estadístico de la República de Cuba. La Habana: MINSAP; 2011.

  5. Ministerio de Salud Pública (MINSAP). Programa Nacional de Prevención y Control de las Enfermedades Cerebrovascular (ECV). La Habana: MINSAP; 2005 [citado 10 Jul 2008]. Disponible en: http://www.pdcorynthia.sld.cu/Documentos/Programas%20APS /prog%20prevencion%20y%20control%20enf%20cerebrovasculares.pdf

  6. Zuaznábar MA, Concepcián OF, Marre GC, Vidal RM. Epidemiology of Cerebrovascular Diseases in Cuba, 1970 to 2006. MEDICC Rev. 2008;10(2):338.

  7. Bosch Ramírez R; Robles MartínezPinillo JA ; Aponte Pupo B. Epidemiología de la enfermedad cerebrovascular en la Isla de la Juventud, 20062009. Rev Cubana Medicina. 2010;49(4):33747.

  8. F. Purroy-García, et al; Factores clínicos predictores de la aparición de episodios vasculares tras un ataque isquémico transitorio angiología 2004; 56 (5): 491-503

  9. Miguel Ángel Buergo Zuaznábar, et al. Guías de práctica clínica. Enfermedad cerebrovascular La Habana: Editorial Ciencias Médicas, 2009. [IX], 170 p. : tab. (Guías de práctica clínica)

  10. Cruz Hernández J. y Col Estrés oxidativo y diabetes mellitusRev Mex Patol Clin, Vol. 58, Núm. 1, pp 4-15 • Enero - Marzo, 2011disponible en http://www.medigraphic.com/patologiaclinica

  11. Menéndez S, González R, Ledea OE, Hernández F, León OS, Díaz M. Ozono. Aspectos básicos y aplicaciones clínicas. La Habana, Cuba: Editorial CENIC; 2008:10-320.

  12. Schwartz A. y colaboradores.Guia para el uso medico del ozono.Fundamnentos terapeuticos e indicaciones.Madrid, España .Edicion Integral http://www.gaap.es M -36090-2011:39-65

  13. Aleksandrov V.N., Danilenko E.A., Mingalev V.V., Sulga R.N. Curso del periodo de rehabilitación en enfermos con trastornos cerebrovasculares. // El ozono en Biología y Medicina. Resúmenes de la 2da conferencia científico-práctica Ruso- Ucraniana.- Odesa.-2004.-p. 6.

  14. Viebhahn-Hánsler R. The use of ozone in Medicine .5th English edition. Germany: ODREI Publishers, 2007:148-155.

  15. Loscalzo J. The relation between atherosclerosis and thrombosis. Circulation 1992;86 (Supl 3):95-99.

  16. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in ahterosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31:1.217-1.225.

  17. V. Bocci, E. Borrelli, V.Travagli, I. Zanardi. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Medicinal Research Reviews 2009, 4: 646- 682.

  18. Friman M, Walter D, Eng L, Menéndez S, Gómez M. Efecto del ozono en las células endoteliales circulantes en ratas. Rev CENIC Ciencias Biológicas (Cuba) 1989;20(1-2-3):25-8.

  19. Furchgott RF, Zawadzki JV. The obligatory role of endotelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288;373-6.

  20. Nobis U, Pries AR, Cokelet GR, Gaehtgens P. Radial distribution of white cells during blood flow in small tubes. Microvasc Res 1985;29:295-304.

  21. Borroto Rodríguez V, Morejón Reina L, Cambara Peña R, Menéndez Cepero S. Ozonoterapia en el tratamiento de las microvárices de miembros inferiores. Contribuciones al Desarrollo de La Hidrología Médica, Medicina Natural y Tradicional. Centro Nacional de Medicina Natural y Tradicional (Primera Edición) Geotech, La Habana, 26 pp, 2010. ISBN 959-7167-21-2.

  22. Ernesto Basabe, Vivian Borroto Luis Bell, Silvia Menéndez, Carlos López, María de los Ángeles Alarcón; Respuesta mediante efecto Doppler del tronco vertebrovacilar de pacientes con síndrome cocleovestivular incompleto tratados con ozonoterapia y acupuntura. Revista CENIC Ciencias Biológicas, Vol. 29, No 3 1998.

  23. Arboix A, Díaz A, Pérez-Sempere A, ÁlvarezSabín J. Ictus: tipos etiológicos y criterios diagnósticos.Neurología 2002; 17 (Supl 3): 3-12.

  24. Matías-Guiu J, Oltra A, Falip R, Galiano L.Occurrence of transient ischemic attacks in Alcoi: Descriptive epidemiology. Neuroepidemiology 1994; 13: 34-9.

  25. López-Pousa S, Vilalta J, Llinás J. Incidencia de la enfermedad vascular cerebral en España: estudio en un área rural de Girona. Rev Neurol 1995; 123: 1081-6.

  26. Sempere AP, Duarte J, Cabezas C, Clavería LE. Incidence of transient ischemic attacks and minor ischemic strokes in Segovia, Spain. Stroke 1996; 27: 667-71.

  27. Ovbiagele B, Kidwell CS, Saver JL. Epidemiological impact in the USA of a tissuebased definition of TIA. Stroke 2003; 34: 919-24.

  28. National Stroke Association. TIA/mini strokes: public knowledge and experience Roper Starch worldwide survey. Roper Starch Worldwide; 2000.

  29. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284: 2901-6.

  30. Heyman A, Wilkinson WE, Hurwitz BJ, Haynes CS, Utley CM, Rosati RA, et al. Risk of ischemic heart disease in patients with TIA. Neurology 1984; 34: 626-30. Revista Cubana de Medicina Física y Rehabilitación 2013;5(1):3-16 16

  31. Clark TG, Murphy MFG, Rothwell PM. Long term risks of stroke, myocardial infarction, and vascular death in `low risk' patients with non-recent transient ischemic attack. J Neurol Neurosurg Psychiatry 2003; 74: 577-80.




2020     |     www.medigraphic.com